A Brief History of Ekso Bionics Holdings, Inc. (EKSO)

Ekso Bionics Holdings, Inc. is a leading company in the field of exoskeleton technology, providing robotic exoskeletons for medical and industrial use. The company has a rich history dating back to its founding in 2005.

• 2005: Ekso Bionics was founded by Homayoon Kazerooni and Russ Angold at the University of California, Berkeley, with the goal of developing exoskeleton technology for medical and industrial applications.
• 2012: The company officially changed its name to Ekso Bionics Holdings, Inc. and went public on the NASDAQ stock exchange under the ticker symbol EKSO.
• 2013: Ekso Bionics launched its first commercially available medical exoskeleton, Ekso GT, designed to help individuals with lower body paralysis or weakness to walk again.
• 2016: The company expanded its product line to include the EksoVest, a passive exoskeleton for industrial use to reduce worker fatigue and prevent injury.
• 2020: Ekso Bionics continued to innovate and improve its exoskeleton technology, receiving FDA clearance for the EksoNR, a next-generation medical exoskeleton with advanced features for gait training and rehabilitation.

Who Owns Ekso Bionics Holdings, Inc. (EKSO)

Ekso Bionics Holdings, Inc. (EKSO) is a company that specializes in the design, development, and sale of exoskeleton technology for the healthcare, industrial, military, and consumer markets. The ownership of Ekso Bionics Holdings, Inc. is made up of a combination of institutional investors and individual shareholders.

Institutional Investors:

• Vanguard Group Inc.: Vanguard Group Inc. is one of the largest institutional investors in Ekso Bionics Holdings, Inc. They hold a significant amount of shares in the company.
• BlackRock, Inc.: BlackRock, Inc. is another major institutional investor in Ekso Bionics Holdings, Inc. They also hold a substantial stake in the company.

Individual Shareholders:

• Max Scheder-Bieschin: Max Scheder-Bieschin is the Chief Executive Officer of Ekso Bionics Holdings, Inc. and one of the largest individual shareholders in the company.
• Russ Angold: Russ Angold is the Co-Founder and Chief Technology Officer of Ekso Bionics Holdings, Inc. He is also a significant individual shareholder in the company.

Ekso Bionics Holdings, Inc. (EKSO) Mission Statement

Ekso Bionics Holdings, Inc. is committed to transforming the lives of individuals by developing exoskeleton technology that enhances human mobility and productivity. Our mission is to empower individuals with limited mobility to regain independence and improve their quality of life through innovative robotic solutions.

At Ekso Bionics, we strive to push the boundaries of what is possible in the field of exoskeleton technology. By combining cutting-edge engineering with a deep understanding of human biomechanics, we aim to create exoskeletons that not only provide physical support but also enhance overall well-being for our users.

• Innovation: We are dedicated to continuous innovation and improvement in our technology to provide the best possible solutions for individuals with mobility challenges.
• Empowerment: We believe in empowering individuals to regain control over their lives and achieve new levels of independence through our exoskeleton technology.
• Quality of Life: Our ultimate goal is to enhance the quality of life for our users by enabling greater mobility, functionality, and overall well-being.

How Ekso Bionics Holdings, Inc. (EKSO) Works

Ekso Bionics Holdings, Inc. is a leading developer of exoskeleton technology for medical and industrial use. The company's mission is to improve human mobility, strength, and endurance through its innovative robotic exoskeletons.

Ekso Bionics primarily focuses on two main markets: medical exoskeletons and industrial exoskeletons. Their medical exoskeletons are designed to help individuals with mobility impairments due to spinal cord injuries, stroke, or other conditions regain the ability to walk and improve their quality of life. On the other hand, their industrial exoskeletons are aimed at reducing the risk of work-related injuries and enhancing productivity for workers in industries such as construction, manufacturing, and logistics.

Here is how Ekso Bionics Holdings, Inc. works:

• Research and Development: The company invests heavily in research and development to improve its exoskeleton technology and create new products that meet the needs of its target markets.
• Product Development: Ekso Bionics designs and manufactures its exoskeletons, ensuring that they are safe, reliable, and effective for their intended applications.
• Clinical Trials and Regulatory Approval: Before launching a new medical exoskeleton, Ekso Bionics conducts clinical trials to demonstrate its effectiveness and safety. The company also obtains regulatory approval from relevant authorities to market its products.
• Commercialization: Once a product is ready for market, Ekso Bionics works on commercializing it by partnering with healthcare facilities, rehabilitation centers, and industrial companies to make its exoskeletons available to those who can benefit from them.
• Customer Support: The company provides training and support to customers using its exoskeletons to ensure they can maximize the benefits of the technology.

How Ekso Bionics Holdings, Inc. (EKSO) Makes Money

Ekso Bionics Holdings, Inc. generates revenue through several key sources, including:

• Sales of exoskeleton products: Ekso Bionics designs and manufactures exoskeletons for medical and industrial applications. These wearable robotic devices are sold to hospitals, rehabilitation centers, and other healthcare facilities for use in rehabilitation therapy and assistance with mobility.
• Rental and leasing services: In addition to selling exoskeletons, Ekso Bionics offers rental and leasing options for customers who may not want to make a full purchase. This allows healthcare facilities to use the exoskeletons on a temporary basis without committing to a long-term investment.
• Service contracts: Ekso Bionics also generates revenue through service contracts, providing maintenance and repair services for its exoskeleton products. This ongoing support helps customers ensure the proper functioning of their devices and extends the life of their investment.
• Research and development partnerships: The company collaborates with research institutions, universities, and industry partners on projects to advance the technology and capabilities of its exoskeletons. These partnerships can lead to grants, funding, and licensing agreements that contribute to Ekso Bionics' revenue stream.
• Training and education programs: Ekso Bionics offers training and education programs for healthcare professionals, therapists, and end-users to learn how to effectively use and integrate exoskeleton technology into their practice. These programs generate revenue through registration fees and consulting services.